chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Ejection fraction normal, Pericardial effusion, Pericarditis, Red blood cell sedimentation rate increased
Clinical narrative: accompanied with very severe chest pain; Pericarditis; woke up with a severe headache; severe pain; continues to have muscle pain; weakness; shortness of breath when she walks; This is a spontaneous report from a contactable consumer.  A 75-year-old female patient received first dose of BNT162B2 (lot number and expiry date not provided), via an unspecified route of administration on 15Jan2021 10:30 at single dose for COVID-19 immunization. There were no medical history. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. On 16Jan2021 04:00, she went to bed at night and woke up at 4 AM with a severe headache. She took Aleve and went back to bed. When she woke up at 8:30 AM her headache was very severe and was accompanied with very severe chest pain. She immediately took her to the ER. They did a very thorough work up to check on her heart and Aorta. They managed her severe pain with two doses of morphine followed by two days of Dilaudid. The imaging and symptoms left her with a newly discovered diagnosis of Pericarditis. The medical professions were sure this was a result of the COVID vaccine. They continued to treat her for a few days and sent her home with anti inflammatories to help. She continues to have muscle pain, weakness and shortness of breath when she walks. She is scheduled to take her 2nd dose on February 5th but we are very concerned and hesitant as we don't want to cause any more damage to her heart. The patient was hospitalized for events 'headache', 'chest pain;', 'pericarditis' and 'pain' for 4 days. The patient did not receive any other vaccines within four weeks prior to the vaccination and did not received any other medications within 2 weeks of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests and procedures which included imaging: pericarditis on 16Jan2021 and Nasal Swab: negative on 16Jan2021. Therapeutic measures were taken as a result of all the events which included Colchicine and prednisone, morphine and dilaudid. The outcome of the events was recovering. The events "headache", "chest pain", "pericarditis"and "severe pain" were assessed as serious due to hospitalization and disability. The events "myalgia", "asthenia" and "dyspnea" were assessed as serious due to disability. The events ('headache', 'chest pain;', 'pericarditis' and 'pain') resulted in emergency room visit.   Information on the lot/batch number has been requested.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Nausea, Vaccine positive rechallenge, Visual impairment, Vomiting
Clinical narrative: Patient complained of visual changes, shakiness, N/V  and fatigue. Remained in Observation Area (clinic) extended by per RN. VS assessed frequently. EMS called due to patients condition not improved but worsening and transported to ER. Patient noted similar reaction with first vaccine. Patient had COVID in September.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Nausea, Tremor, Visual impairment, Vomiting
Clinical narrative: Patient complained of visual changes, shakiness, N/V  and fatigue. Remained in Observation Area (clinic) extended by per RN. VS assessed frequently. EMS called due to patients condition not improved but worsening and transported to ER. Patient noted similar reaction with first vaccine. Patient had COVID in September.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Headache, Hypoaesthesia, Magnetic resonance imaging head, Pain in extremity
Clinical narrative: "Patient states that she received the first dose of the Pfizer COVID vaccination on 1/2/21. Approximately 30 minutes later, she started having left arm numbness and shooting pain. This has not occurred with any previous vaccinations. Over the course of the next several hours, numbness spread to involve her left foot and she felt like her knee was swollen. The day after, she started having numbness in her right foot and some in her right hand/fingers. Her left sided symptoms seem to have improved, but her right sided numbness persisted/worsened. Felt subjectively warm and generally weak/tired. No similar episodes in the past and no prior episode of other focal neurologic deficits. "  Sensory changes and paresthesias present daily and slowly improving for the following weeks.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Asthenia, Blood test, Computerised tomogram, Fatigue
Clinical narrative: "Patient states that she received the first dose of the Pfizer COVID vaccination on 1/2/21. Approximately 30 minutes later, she started having left arm numbness and shooting pain. This has not occurred with any previous vaccinations. Over the course of the next several hours, numbness spread to involve her left foot and she felt like her knee was swollen. The day after, she started having numbness in her right foot and some in her right hand/fingers. Her left sided symptoms seem to have improved, but her right sided numbness persisted/worsened. Felt subjectively warm and generally weak/tired. No similar episodes in the past and no prior episode of other focal neurologic deficits. "  Sensory changes and paresthesias present daily and slowly improving for the following weeks.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Hypoaesthesia, Inflammatory marker test, Joint swelling, Magnetic resonance imaging
Clinical narrative: "Patient states that she received the first dose of the Pfizer COVID vaccination on 1/2/21. Approximately 30 minutes later, she started having left arm numbness and shooting pain. This has not occurred with any previous vaccinations. Over the course of the next several hours, numbness spread to involve her left foot and she felt like her knee was swollen. The day after, she started having numbness in her right foot and some in her right hand/fingers. Her left sided symptoms seem to have improved, but her right sided numbness persisted/worsened. Felt subjectively warm and generally weak/tired. No similar episodes in the past and no prior episode of other focal neurologic deficits. "  Sensory changes and paresthesias present daily and slowly improving for the following weeks.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Serum ferritin, Thyroid function test, Vitamin D
Clinical narrative: "Patient states that she received the first dose of the Pfizer COVID vaccination on 1/2/21. Approximately 30 minutes later, she started having left arm numbness and shooting pain. This has not occurred with any previous vaccinations. Over the course of the next several hours, numbness spread to involve her left foot and she felt like her knee was swollen. The day after, she started having numbness in her right foot and some in her right hand/fingers. Her left sided symptoms seem to have improved, but her right sided numbness persisted/worsened. Felt subjectively warm and generally weak/tired. No similar episodes in the past and no prior episode of other focal neurologic deficits. "  Sensory changes and paresthesias present daily and slowly improving for the following weeks.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Feeling hot, Injection site pain, Nausea, Pyrexia
Clinical narrative: fever (mentioned 99.4); chills; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age received  BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, in Jan2021 as the second dose, for COVID-19 immunization.  Medical history included rotator cuff surgery 5 weeks ago inDec2020.  There were no concomitant medications.  The patient reported a rotator cuff surgery 5 weeks ago and received a second dose of the COVID vaccine in Jan2021 and experienced a  fever (mentioned 99.4) and chills. The outcome of the events of fever and chills was not reported.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: fever (mentioned 99.4); chills; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age received  BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, in Jan2021 as the second dose, for COVID-19 immunization.  Medical history included rotator cuff surgery 5 weeks ago inDec2020.  There were no concomitant medications.  The patient reported a rotator cuff surgery 5 weeks ago and received a second dose of the COVID vaccine in Jan2021 and experienced a  fever (mentioned 99.4) and chills. The outcome of the events of fever and chills was not reported.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: fever (mentioned 99.4); chills; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age received  BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, in Jan2021 as the second dose, for COVID-19 immunization.  Medical history included rotator cuff surgery 5 weeks ago inDec2020.  There were no concomitant medications.  The patient reported a rotator cuff surgery 5 weeks ago and received a second dose of the COVID vaccine in Jan2021 and experienced a  fever (mentioned 99.4) and chills. The outcome of the events of fever and chills was not reported.  Information on the lot/batch number has been requested.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Injection site rash, Nausea, Rash
Clinical narrative: Patient is a 70 y.o. female presenting to the ED with chief complaint of generalized feeling unwell, nausea, vomiting, dizziness, weakness. Patient had Covid 1 month ago. She received her first COVID-19 vaccine Moderna version yesterday. Cough well last evening. This morning started having symptoms. Overall just feels weak dizzy with vomiting. In addition to the other symptoms patient has noticed some diffuse erythema redness to her left side of her body. Did receive her vaccine on the left side. No alleviating factors. No specific aggravating factors. Diffuse body aches but no specific focal pain. No passing out. Dizziness and weakness is worse with exertion. No other complaints
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Patient is a 70 y.o. female presenting to the ED with chief complaint of generalized feeling unwell, nausea, vomiting, dizziness, weakness. Patient had Covid 1 month ago. She received her first COVID-19 vaccine Moderna version yesterday. Cough well last evening. This morning started having symptoms. Overall just feels weak dizzy with vomiting. In addition to the other symptoms patient has noticed some diffuse erythema redness to her left side of her body. Did receive her vaccine on the left side. No alleviating factors. No specific aggravating factors. Diffuse body aches but no specific focal pain. No passing out. Dizziness and weakness is worse with exertion. No other complaints
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Cough, Dizziness, Erythema, Malaise
Clinical narrative: Patient is a 70 y.o. female presenting to the ED with chief complaint of generalized feeling unwell, nausea, vomiting, dizziness, weakness. Patient had Covid 1 month ago. She received her first COVID-19 vaccine Moderna version yesterday. Cough well last evening. This morning started having symptoms. Overall just feels weak dizzy with vomiting. In addition to the other symptoms patient has noticed some diffuse erythema redness to her left side of her body. Did receive her vaccine on the left side. No alleviating factors. No specific aggravating factors. Diffuse body aches but no specific focal pain. No passing out. Dizziness and weakness is worse with exertion. No other complaints
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Vomiting
Clinical narrative: Patient is a 70 y.o. female presenting to the ED with chief complaint of generalized feeling unwell, nausea, vomiting, dizziness, weakness. Patient had Covid 1 month ago. She received her first COVID-19 vaccine Moderna version yesterday. Cough well last evening. This morning started having symptoms. Overall just feels weak dizzy with vomiting. In addition to the other symptoms patient has noticed some diffuse erythema redness to her left side of her body. Did receive her vaccine on the left side. No alleviating factors. No specific aggravating factors. Diffuse body aches but no specific focal pain. No passing out. Dizziness and weakness is worse with exertion. No other complaints
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram ST segment elevation, Palpitations
Clinical narrative: Patient presented to the ED where she received vaccination from Public Health. 20 minutes post vaccination became dizzy and experienced SOB. EMS transported. EMS EKG showed possible STEMI. EKG in ED showed t-wave inversions in V-5 and V-6. Patient complaining of SOB. Patient noted feeling better on arrival to ED. Troponin negative in ED. EKG normal. CT head normal. Information on vaccine administered not available as given at another facility. Submission provided by receiving facility for ER services.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head, Computerised tomogram normal, Dizziness, Dyspnoea, Electrocardiogram normal
Clinical narrative: Patient presented to the ED where she received vaccination from Public Health. 20 minutes post vaccination became dizzy and experienced SOB. EMS transported. EMS EKG showed possible STEMI. EKG in ED showed t-wave inversions in V-5 and V-6. Patient complaining of SOB. Patient noted feeling better on arrival to ED. Troponin negative in ED. EKG normal. CT head normal. Information on vaccine administered not available as given at another facility. Submission provided by receiving facility for ER services.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Head discomfort, Headache, Pain, Pyrexia
Clinical narrative: fever,H/A,chils. Presents with HA, chills, fever. Received second moderna COVID vaccine on 2/3. HISTORY OF PRESENT ILLNESS: 19-year-old male presents with headache, body aches and subjective fever following second COVID vaccination.  She received a vaccination 2 days ago, and yesterday developed acute onset of generalized body aches, mild, constant with gradual onset of bitemporal frontal pressure headache, similar to priors.  He also reports subjective fevers but has not checked his temperature.  He took Motrin yesterday with some improvement.  Denies objective fever, chills, nausea, vomiting, neck pain, vision changes, chest pain, dyspnea, abdominal pain, back pain, weakness or numbness.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Head discomfort, Headache, Pain, Pyrexia
Clinical narrative: fever,H/A,chils. Presents with HA, chills, fever. Received second moderna COVID vaccine on 2/3. HISTORY OF PRESENT ILLNESS: 19-year-old male presents with headache, body aches and subjective fever following second COVID vaccination.  She received a vaccination 2 days ago, and yesterday developed acute onset of generalized body aches, mild, constant with gradual onset of bitemporal frontal pressure headache, similar to priors.  He also reports subjective fevers but has not checked his temperature.  He took Motrin yesterday with some improvement.  Denies objective fever, chills, nausea, vomiting, neck pain, vision changes, chest pain, dyspnea, abdominal pain, back pain, weakness or numbness.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Nasopharyngitis, Pain
Clinical narrative: He feels lousy himself; This is a spontaneous report from a contactable consumer, reporting for himself.  A male patient of an unspecified age received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 20Jan2021 as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. The patient received his first dose of BNT162B2 on an unspecified date for covid-19 vaccination. On an unspecified date in Jan2021, the patient stated that he feels lousy. The clinical outcome of he feels lousy was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise
Clinical narrative: He feels lousy himself; This is a spontaneous report from a contactable consumer, reporting for himself.  A male patient of an unspecified age received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 20Jan2021 as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. The patient received his first dose of BNT162B2 on an unspecified date for covid-19 vaccination. On an unspecified date in Jan2021, the patient stated that he feels lousy. The clinical outcome of he feels lousy was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness, Wheezing
Clinical narrative: Received vaccine at 2:10 pm.  Approx 10 minutes later started feeling anxious and mild tightness in the throat. Left clinic after 30 minutes not realizing I was having a reaction.  About 35 minutes after injection started feeling lightheaded, more anxious, and slightly confused.  Drove home for 20min.  Once home (approx 3pm) I gave myself 2 doses of Epipen Jr., 25 mg Benadryl, and 20 mg Pepcid.  I started feeling better, thinking clearer.  Approx 10 minutes later I again became slightly confused and anxious and began having increased throat tightness, chest tightness, and cough. After continuing to not improve I went to Urgent Care arriving approx 4 pm.  At that time I was given 40 mg prednisone and another dose (0.3mg) of sq epinephrine.  I immediately had improvement in breathing, thinking, and throat tightness.  I continued to have mild throat clearing and cough for approx 24 hours.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Chest discomfort, Confusional state, Cough, Dizziness
Clinical narrative: Received vaccine at 2:10 pm.  Approx 10 minutes later started feeling anxious and mild tightness in the throat. Left clinic after 30 minutes not realizing I was having a reaction.  About 35 minutes after injection started feeling lightheaded, more anxious, and slightly confused.  Drove home for 20min.  Once home (approx 3pm) I gave myself 2 doses of Epipen Jr., 25 mg Benadryl, and 20 mg Pepcid.  I started feeling better, thinking clearer.  Approx 10 minutes later I again became slightly confused and anxious and began having increased throat tightness, chest tightness, and cough. After continuing to not improve I went to Urgent Care arriving approx 4 pm.  At that time I was given 40 mg prednisone and another dose (0.3mg) of sq epinephrine.  I immediately had improvement in breathing, thinking, and throat tightness.  I continued to have mild throat clearing and cough for approx 24 hours.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: Received vaccine at 2:10 pm.  Approx 10 minutes later started feeling anxious and mild tightness in the throat. Left clinic after 30 minutes not realizing I was having a reaction.  About 35 minutes after injection started feeling lightheaded, more anxious, and slightly confused.  Drove home for 20min.  Once home (approx 3pm) I gave myself 2 doses of Epipen Jr., 25 mg Benadryl, and 20 mg Pepcid.  I started feeling better, thinking clearer.  Approx 10 minutes later I again became slightly confused and anxious and began having increased throat tightness, chest tightness, and cough. After continuing to not improve I went to Urgent Care arriving approx 4 pm.  At that time I was given 40 mg prednisone and another dose (0.3mg) of sq epinephrine.  I immediately had improvement in breathing, thinking, and throat tightness.  I continued to have mild throat clearing and cough for approx 24 hours.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebellar infarction, Magnetic resonance imaging brain abnormal, Muscular weakness, Platelet count decreased
Clinical narrative: Possible idiopathic thrombocytopenia purpura from first COVID vaccine (Pfizer) received outpatient. Onset of dizziness/gait problem symptoms occurred possibly 5 days after vaccine given. Upon admission patient was found to have thrombocytopenia with no changes in medications and upon MRI an acute stroke.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Dizziness, Gait disturbance, Magnetic resonance imaging abnormal, Thrombocytopenia
Clinical narrative: Possible idiopathic thrombocytopenia purpura from first COVID vaccine (Pfizer) received outpatient. Onset of dizziness/gait problem symptoms occurred possibly 5 days after vaccine given. Upon admission patient was found to have thrombocytopenia with no changes in medications and upon MRI an acute stroke.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Rash
Clinical narrative: BC received the COVID vaccine around 445pm and waited the recommended observation period and left.  BC returned to clinic at approx. 615 with redness and hives on neck and chest and left sided facial swelling.  BC stated she noticed the hives around 545 pm and came back to the clinic.  Public Health Nurse assessed BC at 615 pm.  Redness and hives noted from top of neck to upper chest.  When BC took face mask off, swelling noticed along left jawline.  Blood pressure 140/100, pulse 92 and regular.  BC breathing easy, no shortness of breath, BC denies any feeling of "lump in throat", difficulty swallowing or difficulty.  BC appeared anxious, no sweating noted, facial skin color appeared flushed on cheeks, ears and neck and chest, skin warm to touch.  Public Health Nurse administered (20 ml) 50mg of liquid Benadryl.  PHN recommended that BC follow up with the ER.  BC contacted her physician.  BC's physician also recommended that she follow up with ER.  At 655pm, BC hives and redness on neck and chest disappearing, BC felt more calm, BP 112/82, pulse 72 and regular.  BC had a friend pick her up and take her to the hospital for follow up.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Erythema, Flushing, Skin warm, Swelling face
Clinical narrative: BC received the COVID vaccine around 445pm and waited the recommended observation period and left.  BC returned to clinic at approx. 615 with redness and hives on neck and chest and left sided facial swelling.  BC stated she noticed the hives around 545 pm and came back to the clinic.  Public Health Nurse assessed BC at 615 pm.  Redness and hives noted from top of neck to upper chest.  When BC took face mask off, swelling noticed along left jawline.  Blood pressure 140/100, pulse 92 and regular.  BC breathing easy, no shortness of breath, BC denies any feeling of "lump in throat", difficulty swallowing or difficulty.  BC appeared anxious, no sweating noted, facial skin color appeared flushed on cheeks, ears and neck and chest, skin warm to touch.  Public Health Nurse administered (20 ml) 50mg of liquid Benadryl.  PHN recommended that BC follow up with the ER.  BC contacted her physician.  BC's physician also recommended that she follow up with ER.  At 655pm, BC hives and redness on neck and chest disappearing, BC felt more calm, BP 112/82, pulse 72 and regular.  BC had a friend pick her up and take her to the hospital for follow up.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: BC received the COVID vaccine around 445pm and waited the recommended observation period and left.  BC returned to clinic at approx. 615 with redness and hives on neck and chest and left sided facial swelling.  BC stated she noticed the hives around 545 pm and came back to the clinic.  Public Health Nurse assessed BC at 615 pm.  Redness and hives noted from top of neck to upper chest.  When BC took face mask off, swelling noticed along left jawline.  Blood pressure 140/100, pulse 92 and regular.  BC breathing easy, no shortness of breath, BC denies any feeling of "lump in throat", difficulty swallowing or difficulty.  BC appeared anxious, no sweating noted, facial skin color appeared flushed on cheeks, ears and neck and chest, skin warm to touch.  Public Health Nurse administered (20 ml) 50mg of liquid Benadryl.  PHN recommended that BC follow up with the ER.  BC contacted her physician.  BC's physician also recommended that she follow up with ER.  At 655pm, BC hives and redness on neck and chest disappearing, BC felt more calm, BP 112/82, pulse 72 and regular.  BC had a friend pick her up and take her to the hospital for follow up.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blood test normal, Chest discomfort, Diarrhoea, Dyspnoea
Clinical narrative: Severe chills; Severe lower extremity pain; Headache; Body ache; Shooting joint pain; Nausea; Vomiting; Diarrhea; Fever; Sore throat; Swollen glands; Sweating; This is a spontaneous report from a contactable other health professional (patient). A 38-year-old female (not pregnant) patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1283), intramuscular at left arm on 12Jan2021 22:45 at single dose for COVID-19 immunization at a hospital. Medical history included asthma and attention deficit hyperactivity disorder (ADD). Concomitant medication within 2 weeks prior to the COVID vaccine included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took sumatriptan succinate (IMITREX) and experienced drug allergy (known allergies: Imitrex). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1284), intramuscular at left arm on 22Dec2020 15:30 for COVID-19 immunization at a hospital. The patient had no COVID prior to vaccination, and had been tested for COVID since the vaccination. The patient underwent lab tests and procedures post vaccination which included 2019 Novel Coronavirus RNA Testing by PCR (Nasal Swab) on 21Jan2021: negative, and Influenza/COVID-19 Nucleic Acid Amplification Test (Nasal Swab) on 18Jan2021: negative. It was reported that, started from 12Jan2021 23:30, the patient experienced severe chills, headache, body ache, shooting joint pain, nausea, vomiting, diarrhea, fever, sore throat, swollen glands, severe lower extremity pain, and sweating. All the events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. No treatment was received for the above events. The outcome of all the events was not recovered.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Face and mouth X-ray, Fatigue, Headache, Influenza A virus test negative, Influenza B virus test
Clinical narrative: Severe chills; Severe lower extremity pain; Headache; Body ache; Shooting joint pain; Nausea; Vomiting; Diarrhea; Fever; Sore throat; Swollen glands; Sweating; This is a spontaneous report from a contactable other health professional (patient). A 38-year-old female (not pregnant) patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1283), intramuscular at left arm on 12Jan2021 22:45 at single dose for COVID-19 immunization at a hospital. Medical history included asthma and attention deficit hyperactivity disorder (ADD). Concomitant medication within 2 weeks prior to the COVID vaccine included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took sumatriptan succinate (IMITREX) and experienced drug allergy (known allergies: Imitrex). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1284), intramuscular at left arm on 22Dec2020 15:30 for COVID-19 immunization at a hospital. The patient had no COVID prior to vaccination, and had been tested for COVID since the vaccination. The patient underwent lab tests and procedures post vaccination which included 2019 Novel Coronavirus RNA Testing by PCR (Nasal Swab) on 21Jan2021: negative, and Influenza/COVID-19 Nucleic Acid Amplification Test (Nasal Swab) on 18Jan2021: negative. It was reported that, started from 12Jan2021 23:30, the patient experienced severe chills, headache, body ache, shooting joint pain, nausea, vomiting, diarrhea, fever, sore throat, swollen glands, severe lower extremity pain, and sweating. All the events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. No treatment was received for the above events. The outcome of all the events was not recovered.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lymphadenopathy, Malaise, Mononucleosis heterophile test negative, Musculoskeletal stiffness, Nasopharyngitis
Clinical narrative: Severe chills; Severe lower extremity pain; Headache; Body ache; Shooting joint pain; Nausea; Vomiting; Diarrhea; Fever; Sore throat; Swollen glands; Sweating; This is a spontaneous report from a contactable other health professional (patient). A 38-year-old female (not pregnant) patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1283), intramuscular at left arm on 12Jan2021 22:45 at single dose for COVID-19 immunization at a hospital. Medical history included asthma and attention deficit hyperactivity disorder (ADD). Concomitant medication within 2 weeks prior to the COVID vaccine included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took sumatriptan succinate (IMITREX) and experienced drug allergy (known allergies: Imitrex). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1284), intramuscular at left arm on 22Dec2020 15:30 for COVID-19 immunization at a hospital. The patient had no COVID prior to vaccination, and had been tested for COVID since the vaccination. The patient underwent lab tests and procedures post vaccination which included 2019 Novel Coronavirus RNA Testing by PCR (Nasal Swab) on 21Jan2021: negative, and Influenza/COVID-19 Nucleic Acid Amplification Test (Nasal Swab) on 18Jan2021: negative. It was reported that, started from 12Jan2021 23:30, the patient experienced severe chills, headache, body ache, shooting joint pain, nausea, vomiting, diarrhea, fever, sore throat, swollen glands, severe lower extremity pain, and sweating. All the events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. No treatment was received for the above events. The outcome of all the events was not recovered.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pharyngeal ulceration, Pyrexia, SARS-CoV-2 test negative, Sneezing
Clinical narrative: Severe chills; Severe lower extremity pain; Headache; Body ache; Shooting joint pain; Nausea; Vomiting; Diarrhea; Fever; Sore throat; Swollen glands; Sweating; This is a spontaneous report from a contactable other health professional (patient). A 38-year-old female (not pregnant) patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1283), intramuscular at left arm on 12Jan2021 22:45 at single dose for COVID-19 immunization at a hospital. Medical history included asthma and attention deficit hyperactivity disorder (ADD). Concomitant medication within 2 weeks prior to the COVID vaccine included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took sumatriptan succinate (IMITREX) and experienced drug allergy (known allergies: Imitrex). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1284), intramuscular at left arm on 22Dec2020 15:30 for COVID-19 immunization at a hospital. The patient had no COVID prior to vaccination, and had been tested for COVID since the vaccination. The patient underwent lab tests and procedures post vaccination which included 2019 Novel Coronavirus RNA Testing by PCR (Nasal Swab) on 21Jan2021: negative, and Influenza/COVID-19 Nucleic Acid Amplification Test (Nasal Swab) on 18Jan2021: negative. It was reported that, started from 12Jan2021 23:30, the patient experienced severe chills, headache, body ache, shooting joint pain, nausea, vomiting, diarrhea, fever, sore throat, swollen glands, severe lower extremity pain, and sweating. All the events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. No treatment was received for the above events. The outcome of all the events was not recovered.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Spinal pain, Streptococcus test negative, Vomiting
Clinical narrative: Severe chills; Severe lower extremity pain; Headache; Body ache; Shooting joint pain; Nausea; Vomiting; Diarrhea; Fever; Sore throat; Swollen glands; Sweating; This is a spontaneous report from a contactable other health professional (patient). A 38-year-old female (not pregnant) patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1283), intramuscular at left arm on 12Jan2021 22:45 at single dose for COVID-19 immunization at a hospital. Medical history included asthma and attention deficit hyperactivity disorder (ADD). Concomitant medication within 2 weeks prior to the COVID vaccine included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took sumatriptan succinate (IMITREX) and experienced drug allergy (known allergies: Imitrex). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1284), intramuscular at left arm on 22Dec2020 15:30 for COVID-19 immunization at a hospital. The patient had no COVID prior to vaccination, and had been tested for COVID since the vaccination. The patient underwent lab tests and procedures post vaccination which included 2019 Novel Coronavirus RNA Testing by PCR (Nasal Swab) on 21Jan2021: negative, and Influenza/COVID-19 Nucleic Acid Amplification Test (Nasal Swab) on 18Jan2021: negative. It was reported that, started from 12Jan2021 23:30, the patient experienced severe chills, headache, body ache, shooting joint pain, nausea, vomiting, diarrhea, fever, sore throat, swollen glands, severe lower extremity pain, and sweating. All the events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. No treatment was received for the above events. The outcome of all the events was not recovered.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Headache, Hyperhidrosis
Clinical narrative: Severe chills; Severe lower extremity pain; Headache; Body ache; Shooting joint pain; Nausea; Vomiting; Diarrhea; Fever; Sore throat; Swollen glands; Sweating; This is a spontaneous report from a contactable other health professional (patient). A 38-year-old female (not pregnant) patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1283), intramuscular at left arm on 12Jan2021 22:45 at single dose for COVID-19 immunization at a hospital. Medical history included asthma and attention deficit hyperactivity disorder (ADD). Concomitant medication within 2 weeks prior to the COVID vaccine included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took sumatriptan succinate (IMITREX) and experienced drug allergy (known allergies: Imitrex). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1284), intramuscular at left arm on 22Dec2020 15:30 for COVID-19 immunization at a hospital. The patient had no COVID prior to vaccination, and had been tested for COVID since the vaccination. The patient underwent lab tests and procedures post vaccination which included 2019 Novel Coronavirus RNA Testing by PCR (Nasal Swab) on 21Jan2021: negative, and Influenza/COVID-19 Nucleic Acid Amplification Test (Nasal Swab) on 18Jan2021: negative. It was reported that, started from 12Jan2021 23:30, the patient experienced severe chills, headache, body ache, shooting joint pain, nausea, vomiting, diarrhea, fever, sore throat, swollen glands, severe lower extremity pain, and sweating. All the events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. No treatment was received for the above events. The outcome of all the events was not recovered.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lymphadenopathy, Nausea, Oropharyngeal pain, Pain, Pain in extremity
Clinical narrative: Severe chills; Severe lower extremity pain; Headache; Body ache; Shooting joint pain; Nausea; Vomiting; Diarrhea; Fever; Sore throat; Swollen glands; Sweating; This is a spontaneous report from a contactable other health professional (patient). A 38-year-old female (not pregnant) patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1283), intramuscular at left arm on 12Jan2021 22:45 at single dose for COVID-19 immunization at a hospital. Medical history included asthma and attention deficit hyperactivity disorder (ADD). Concomitant medication within 2 weeks prior to the COVID vaccine included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took sumatriptan succinate (IMITREX) and experienced drug allergy (known allergies: Imitrex). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1284), intramuscular at left arm on 22Dec2020 15:30 for COVID-19 immunization at a hospital. The patient had no COVID prior to vaccination, and had been tested for COVID since the vaccination. The patient underwent lab tests and procedures post vaccination which included 2019 Novel Coronavirus RNA Testing by PCR (Nasal Swab) on 21Jan2021: negative, and Influenza/COVID-19 Nucleic Acid Amplification Test (Nasal Swab) on 18Jan2021: negative. It was reported that, started from 12Jan2021 23:30, the patient experienced severe chills, headache, body ache, shooting joint pain, nausea, vomiting, diarrhea, fever, sore throat, swollen glands, severe lower extremity pain, and sweating. All the events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. No treatment was received for the above events. The outcome of all the events was not recovered.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Vomiting
Clinical narrative: Severe chills; Severe lower extremity pain; Headache; Body ache; Shooting joint pain; Nausea; Vomiting; Diarrhea; Fever; Sore throat; Swollen glands; Sweating; This is a spontaneous report from a contactable other health professional (patient). A 38-year-old female (not pregnant) patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1283), intramuscular at left arm on 12Jan2021 22:45 at single dose for COVID-19 immunization at a hospital. Medical history included asthma and attention deficit hyperactivity disorder (ADD). Concomitant medication within 2 weeks prior to the COVID vaccine included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took sumatriptan succinate (IMITREX) and experienced drug allergy (known allergies: Imitrex). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number El1284), intramuscular at left arm on 22Dec2020 15:30 for COVID-19 immunization at a hospital. The patient had no COVID prior to vaccination, and had been tested for COVID since the vaccination. The patient underwent lab tests and procedures post vaccination which included 2019 Novel Coronavirus RNA Testing by PCR (Nasal Swab) on 21Jan2021: negative, and Influenza/COVID-19 Nucleic Acid Amplification Test (Nasal Swab) on 18Jan2021: negative. It was reported that, started from 12Jan2021 23:30, the patient experienced severe chills, headache, body ache, shooting joint pain, nausea, vomiting, diarrhea, fever, sore throat, swollen glands, severe lower extremity pain, and sweating. All the events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. No treatment was received for the above events. The outcome of all the events was not recovered.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Flushing, Headache, Swollen tongue, Throat tightness
Clinical narrative: History of Present Illness: This is a 70-year-old female with a history of hypertension, type 2 diabetes, allergy to shellfish and fish oil presenting to the ED with a potential allergic reaction to her first Covid vaccine.  Patient states that she received her vaccine in her right arm, minutes later she started to feel as if her throat and her tongue were swelling.  She was immediately brought down to the ER by hospital staff.  Patient states that she has had reactions in the past like this to fish and this feels exactly the same.  She does have an EpiPen and would have used it but she did not have it with her today.  She feels like her throat is swelling which is causing her to feel short of breath.  She has not developed a rash.  She has not noticed any facial swelling.  No medications were taken prior to the patient being brought down here to the ED.  ED Course as of Feb 04 1543 Thu Feb 04, 2021 1227 Patient reported that she felt like her throat swelling was worsening.  She was given Benadryl, Solu-Medrol, Pepcid.  I have now added epinephrine 0.3 mg IM x1.   1255 I reexamined the patient.  No worsening of tongue or uvular edema.  Still some mild favoring of her voice.  25 mg of additional Benadryl ordered IV.   1353 The patient was seen and evaluated by Dr, the attending ED physician who agreed with my assessment and plan.     1526 I reexamined the patient.  Her tongue and uvular edema have completely resolved.  Baseline speech is back to baseline.    1539 I care of this patient will be turned over to Dr who will assume the care of this patient.  The plan is to observe her until 1830.  If her symptoms remain improved she will be discharged home with prednisone, Benadryl.  She does have plenty of epinephrine at home.  If her symptoms worsen once again then she will require admission.  I discussed this with the patient and she understands.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphonia, Dyspnoea, Pharyngeal swelling, Rash, Swollen tongue
Clinical narrative: History of Present Illness: This is a 70-year-old female with a history of hypertension, type 2 diabetes, allergy to shellfish and fish oil presenting to the ED with a potential allergic reaction to her first Covid vaccine.  Patient states that she received her vaccine in her right arm, minutes later she started to feel as if her throat and her tongue were swelling.  She was immediately brought down to the ER by hospital staff.  Patient states that she has had reactions in the past like this to fish and this feels exactly the same.  She does have an EpiPen and would have used it but she did not have it with her today.  She feels like her throat is swelling which is causing her to feel short of breath.  She has not developed a rash.  She has not noticed any facial swelling.  No medications were taken prior to the patient being brought down here to the ED.  ED Course as of Feb 04 1543 Thu Feb 04, 2021 1227 Patient reported that she felt like her throat swelling was worsening.  She was given Benadryl, Solu-Medrol, Pepcid.  I have now added epinephrine 0.3 mg IM x1.   1255 I reexamined the patient.  No worsening of tongue or uvular edema.  Still some mild favoring of her voice.  25 mg of additional Benadryl ordered IV.   1353 The patient was seen and evaluated by Dr, the attending ED physician who agreed with my assessment and plan.     1526 I reexamined the patient.  Her tongue and uvular edema have completely resolved.  Baseline speech is back to baseline.    1539 I care of this patient will be turned over to Dr who will assume the care of this patient.  The plan is to observe her until 1830.  If her symptoms remain improved she will be discharged home with prednisone, Benadryl.  She does have plenty of epinephrine at home.  If her symptoms worsen once again then she will require admission.  I discussed this with the patient and she understands.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: Patient was hospitalized for evaluation of sudden-onset of abdominal pain, in setting of prior history of liver transplant, chronic immunosuppression, biliary strictures s/p dilations, recurrent admissions for abdominal pain/possible cholangitis.  Inpatient evaluation including blood cultures, MRCP without evidence of acute infection or obstruction.  Symptoms ultimately attributed to constipation, and patient was discharged to home in stable condition 2 days following admission.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Activated partial thromboplastin time, Alanine aminotransferase normal, Anion gap normal, Aspartate aminotransferase increased
Clinical narrative: Patient was hospitalized for evaluation of sudden-onset of abdominal pain, in setting of prior history of liver transplant, chronic immunosuppression, biliary strictures s/p dilations, recurrent admissions for abdominal pain/possible cholangitis.  Inpatient evaluation including blood cultures, MRCP without evidence of acute infection or obstruction.  Symptoms ultimately attributed to constipation, and patient was discharged to home in stable condition 2 days following admission.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Basophil percentage decreased, Bilirubin conjugated, Blood albumin normal, Blood alkaline phosphatase increased, Blood bicarbonate decreased
Clinical narrative: Patient was hospitalized for evaluation of sudden-onset of abdominal pain, in setting of prior history of liver transplant, chronic immunosuppression, biliary strictures s/p dilations, recurrent admissions for abdominal pain/possible cholangitis.  Inpatient evaluation including blood cultures, MRCP without evidence of acute infection or obstruction.  Symptoms ultimately attributed to constipation, and patient was discharged to home in stable condition 2 days following admission.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood bilirubin increased, Blood bilirubin unconjugated increased, Blood calcium decreased, Blood chloride increased, Blood chloride normal
Clinical narrative: Patient was hospitalized for evaluation of sudden-onset of abdominal pain, in setting of prior history of liver transplant, chronic immunosuppression, biliary strictures s/p dilations, recurrent admissions for abdominal pain/possible cholangitis.  Inpatient evaluation including blood cultures, MRCP without evidence of acute infection or obstruction.  Symptoms ultimately attributed to constipation, and patient was discharged to home in stable condition 2 days following admission.